Literature DB >> 316593

A tuberculin skin test survey in Southwestern Ethiopia.

G K Fuller, N Gemeda, D Fuller, V Demerest.   

Abstract

A study to determine the prevalence of positive skin test reactions in an isolated region of southwestern Ethiopia where no previous surveys have been reported is described. Marked differences in the prevalence of positive skin tests between the population groups studied was found. The Dassanetch who live in large villages and have a high population density relative to other groups tested had the highest number of positives (53.7%). The Hamar who live in small scattered homesteads had the lowest number with 11.5%. The Bale, Suri, and Nyangatom who live in small to medium sized settlements had 32.5%, 27.9%, and 20.7% positivity respectively. Sex differences were minimal though men overall had a slightly higher rate than women (41.6% versus 38.9%). Age differences were marked, particularly where prevalence is high with the sharpest increase occurring under 14 years of age. A dispersed settlement pattern offers a distinct advantage in minimizing the incidence of tuberculosis for the populations of southwestern Ethiopia.

Entities:  

Mesh:

Year:  1979        PMID: 316593

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  3 in total

1.  Health status of Ethiopian refugees in the United States.

Authors:  D M Parenti; D Lucas; A Lee; R H Hollenkamp
Journal:  Am J Public Health       Date:  1987-12       Impact factor: 9.308

2.  Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia.

Authors:  Belete Tegbaru; Dawit Wolday; Tsehaynesh Messele; Mengistu Legesse; Yared Mekonnen; Frank Miedema; Debbie van Baarle
Journal:  Clin Vaccine Immunol       Date:  2006-07

3.  Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test.

Authors:  Mengistu Legesse; Gobena Ameni; Gezahegne Mamo; Girmay Medhin; Gunnar Bjune; Fekadu Abebe
Journal:  BMC Infect Dis       Date:  2011-04-09       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.